Showing results (501-510 of 634) with videos related to

Sort By:
Pageof 64
Biogerontology|August 22, 2025
Whole genome sequencing reveals telomere associated genomic differences between healthy and unhealthy aging in a Korean populationJi-Hye Oh, Hyo Jeong Lee, Wonkyung Kim, et al.
International Journal of Nanomedicine|April 29, 2025
Titanium Dioxide Nanoparticle Exposure Provokes Greater Lung Inflammation in Females Than Males in the Context of ObesityJi-Soo Jeong, Hyun Jegal, Je-Won Ko, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2010
Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: a multicenter Phase II studySun Young Kim, Yong Sang Hong, Dae Yong Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II)Paulo M Hoff, Andreas Hochhaus, Bernhard C Pestalozzi, et al.
Investigational New Drugs|July 12, 2012
Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapyYong Sang Hong, Jeeyun Lee, Kyu-pyo Kim, et al.
Gastrointestinal Endoscopy|July 24, 2007
Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patientsJin Hyoung Kim, Ho-Young Song, Ji Hoon Shin, et al.
Clinical Therapeutics|January 13, 2015
Predicting the efficacy of an oral paclitaxel formulation (DHP107) through modeling and simulationHyeong-Seok Lim, Kyun-Seop Bae, Jin-ah Jung, et al.
Journal of Global Oncology|August 8, 2018
Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical TrialsChia-Jui Yen, Kei Muro, Tae-Won Kim, et al.
Investigational New Drugs|February 28, 2014
A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancerJeeyun Lee, Sang Joon Shin, Ik Joo Chung, et al.
The Oncologist|May 5, 2009
Kinase mutations and efficacy of imatinib in Korean patients with advanced gastrointestinal stromal tumorsTae Won Kim, Min-Hee Ryu, Heungnam Lee, et al.
Pageof 64